ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2
Go back to ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2| (NASDAQ: PRQR) | Delayed: 2.33 +0.11 (4.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $13.33 | |||
| Open | $2.35 | 52 Week Low | $3.48 | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.25 | EPS | $0.00 | |||
| Volume | 1,517,033 | |||||
